Larvol Delta - Aspen-Neuroscience-Announces-Positive-12Month-Data-from-its-ASPIRO-Clinical-Trial-in-a-LateBreaking-Oral-Presentation-at-the-ADPD-2026-International-Conference-on-Alzheimers-and-Parkinsons-Diseases

sasineprocel (ANPD001) - Aspen Neurosci

https://www.prnewswire.com/news-releases/aspen-neuroscience-announces-positive-12month-data-from-its-aspiro-clinical-trial-in-a-latebreaking-oral-presentation-at-the-adpd-2026-international-conference-on-alzheimers-and-parkinsons-diseases-302716505.html

Mar 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next